Screener
LifeMD, Inc. LFMD EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by LifeMD, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: LifeMD, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 5:24 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001493152-26-021536
| Line item | 2026 / Three Months Ended March 31, | 2025 / Three Months Ended March 31, |
|---|---|---|
| Basic loss per share | $(0.20) | $(0.02) |
| Diluted (loss) earnings per share attributable to LifeMD, Inc. common stockholders: | ||
| Continuing operations | $(0.20) | $(0.06) |
| Discontinued operations | - | 0.03 |
| Diluted loss per share | $(0.20) | $(0.02) |
| Weighted average number of common shares outstanding: | ||
| Basic | 47,336,060 | 43,135,778 |
| Diluted | 47,336,060 | 43,135,778 |
Item 1. Financial Statements (unaudited) Item
FAQ
- What is LifeMD, Inc.'s EPS (diluted)?
- LifeMD, Inc. (LFMD) reported EPS (diluted) of -$0.20 in Q1 2026.
- How has LifeMD, Inc.'s EPS (diluted) changed year-over-year?
- LifeMD, Inc.'s EPS (diluted) decreased by 900.0% year-over-year, from -$0.02 to -$0.20.
- What is the long-term trend for LifeMD, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), LifeMD, Inc.'s EPS (diluted) has grown at a -42.5% compound annual growth rate (CAGR), from -$2.28 to $0.25.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about LifeMD, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude